| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/25/2004 | US20040058446 Transfecting cells with nucleic acids; gene therapy |
| 03/25/2004 | US20040058444 Bioprosthetic heart valves |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058359 Erbin as a negative regulator of Ras-Raf-Erk signaling |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057946 Forming a solution of protein encapsulated, insoluble gas-filled microbubbles conjugated to biological agent; administering solution to animal; so that protein directs microbubble-conjugated agent to sites of bioprocessing |
| 03/25/2004 | US20040057941 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia |
| 03/25/2004 | US20040057930 Method for the development of an HIV vaccine |
| 03/25/2004 | US20040057928 Use of IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for manufacture of medicament for therapy and/or prophylaxis |
| 03/25/2004 | US20040057871 Functional assay of high-density lipoprotein |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2497226A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 03/25/2004 | CA2497132A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | CA2494274A1 Method and composition for regulating the activity of regulatory t cells |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399593A2 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
| 03/24/2004 | EP1399564A2 Drug metabolizing enzymes |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399540A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
| 03/24/2004 | EP1399480A2 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399462A1 Combined approach to treatment of cancer using a c-myc antisense oligomer |
| 03/24/2004 | EP1399215A2 Tissue-specific endothelial membrane proteins |
| 03/24/2004 | EP1399189A1 Compositions and methods for enhancing nucleic acid transfer into cells |
| 03/24/2004 | EP1399183A2 Chimeric alphavirus replicon particles |
| 03/24/2004 | EP1399182A2 Papillomavirus vaccines |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399168A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399023A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 03/24/2004 | EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/24/2004 | EP0795015B1 Plasmids suitable for il-2 expression |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1483820A Carcinoma of esophagus related gene-2 and use of coding protein thereof |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710037 Method of treating androgen-dependent disorders |
| 03/23/2004 | US6710035 Interstitial introduction of an isolated polynucleotide into a tissue of the vertebrate where polynucleotide is taken up by the cells of the tissue and exerts a therapeutic effect on the vertebrate to provide immune response |
| 03/23/2004 | US6709866 Methods for enhancing survival of a neuron |
| 03/23/2004 | US6709860 Construct comprising adipose-specific promoter operably linked to nucleotide sequence encoding polypeptide comprising specified amino acid sequence |
| 03/23/2004 | US6709858 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709653 Amino acid residues 1 to 265 of sequence 2; psychotic and depressive disorders |
| 03/23/2004 | CA2245576C Process for preparing purified nucleic acid and the use thereof |
| 03/19/2004 | CA2438778A1 Fusion proteins comprising hiv-nef and lngfr and methods of using same |
| 03/18/2004 | WO2004022763A1 Methods and means for improving retroviral integration |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022741A1 Artificial mammalian chromosome |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022579A2 Cellular delivery of natriuretic peptides |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022104A2 Foxp2 and uses thereof |
| 03/18/2004 | WO2004022103A2 Foxp1 and uses thereof |
| 03/18/2004 | WO2004022102A2 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 03/18/2004 | WO2004022077A1 Methods and compositions for tissue regeneration |
| 03/18/2004 | WO2004022003A2 Materials and methods for treatment of allergic diseases |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2003105755A3 Antisense modulation of vegf-c expression |
| 03/18/2004 | WO2003080825A3 Further bmp-2 inducible kinases and the uses thereof |
| 03/18/2004 | WO2003078660A3 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith |
| 03/18/2004 | WO2003078462A3 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003051272A3 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 03/18/2004 | WO2003048361A3 P55pik |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003040314A3 E1-revertant-free adenoviral composition |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003032809A3 Modulation of akt-dependent response to prevent restenosis |
| 03/18/2004 | WO2003025195A3 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof |
| 03/18/2004 | WO2003022202A3 Compositions and methods for treatment of cancer |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002102982A3 Hoxd3 compositions ad methods for improved wound healing |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |